Two Sigma Investments
CRDL

Two Sigma Investments’s Cardiol Therapeutics CRDL Stock Holding History

Two Sigma Investments’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$721K Buy
534,211
+127,276
+31% +$131K ﹤0.01% 3477
2025
Q4 		$388K Buy
406,935
+174,590
+75% +$183K ﹤0.01% 3449
2025
Q3 		$249K Buy
+232,345
New +$282K ﹤0.01% 3301
2024
Q4 		– Sell
-24,666
Closed -$48.8K – 3249
2024
Q3 		$48.8K Buy
+24,666
New +$51.2K ﹤0.01% 2971
2022
Q1 		– Sell
-194,554
Closed -$360K – 2987
2021
Q4 		$360K Buy
+194,554
New +$537K ﹤0.01% 3520

Other funds holding CRDL

MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Two Sigma Investments's CRDL Position: Q1 2026 in Review

Two Sigma Investments increased its Cardiol Therapeutics (CRDL) stake by 31% in Q1 2026, buying an estimated $131K and bringing the position to 534,211 shares worth $721K. The position accounts for ﹤0.01% of the portfolio, ranked #3477.

Two Sigma Investments first reported a position in CRDL in Q4 2021 and has held it in 5 quarters since. 47 funds tracked by Wall St. Rank hold CRDL as of Q1 2026.

  • Two Sigma Investments held 534,211 shares of Cardiol Therapeutics worth $721K as of Q1 2026.
  • Two Sigma Investments bought 127,276 Cardiol Therapeutics shares in Q1 2026, an estimated $131K.
  • Cardiol Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3477 holding.
  • Two Sigma Investments first reported a position in Cardiol Therapeutics in Q4 2021 and has held it in 5 quarters since.
  • 47 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.